Product Information
ISONIAZID 300 MG TABLET is a generic product labeled by American Health Packaging, priced at $3.4133 per EA under NDC 60687055301. Its NADAC has been published 274 times since Dec 16, 2020.
Strength
300 mg/1
Manufacturer
American Health PackagingNDC
60687055301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ISONIAZIDApproval Type
Generic (ANDA)
FDA Application
ANDA080937On Market Since
10/28/2020
Pharmacological Classes
Price Statistics
The NADAC for ISONIAZID 300 MG TABLET has been published 274 times since Dec 16, 2020, and over the history we have for it it has risen 1980.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4133 per EA |
|---|---|
| All-time high | $3.4133 (Jun 24, 2026) |
| All-time low | $0.1489 (Jan 20, 2021) |
| 52-week high | $3.4133 |
| 52-week low | $2.6149 |
| Median price | $0.2215 |
| Average price | $0.8151 |
| Largest weekly change | +1311.5% (May 21, 2025) |
| Weeks tracked | 274 |
| Tracking since | Dec 16, 2020 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ISONIAZID 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ISONIAZID 300 MG TABLET, manufactured by American Health Packaging, is $3.4133 per EA (NDC 60687055301), effective Jun 24, 2026.
How has the price of ISONIAZID 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ISONIAZID 300 MG TABLET has risen 1980.0%. It has been tracked across 274 weekly CMS publications since Dec 16, 2020.
What are the highest and lowest recorded NADAC prices for ISONIAZID 300 MG TABLET?
Since Dec 16, 2020, the NADAC for ISONIAZID 300 MG TABLET has ranged from a low of $0.1489 (Jan 20, 2021) to a high of $3.4133 (Jun 24, 2026), with a median of $0.2215 per EA.
Are there cheaper alternatives to ISONIAZID 300 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ISONIAZID 300 MG TABLET, but none are currently priced below it.
Who manufactures ISONIAZID 300 MG TABLET?
ISONIAZID 300 MG TABLET (NDC 60687055301) is labeled by American Health Packaging, and CMS classifies it as a generic product.
Related Drugs
Same classification